mechanism 1,685 words KG: ent-dise-bfd8f32d 2026-03-31
kind:mechanismsection:mechanismstopic:cbstopic:psptopic:drug-delivery
Contents

Blood-Brain Barrier Dysfunction and Therapeutic Delivery for CBS/PSP

Mechanism Info
NameBlood-Brain Barrier Dysfunction and Therapeutic Delivery for CBS/PSP
Categorykind:mechanism, section:mechanisms, topic:cbs, topic:psp
SummaryBlood-brain barrier dysfunction in corticobasal syndrome and progressive supranuclear palsy, with strategies to enhance therapeutic delivery including permeability enhancers, focused ultrasound, and receptor-mediated transport

Knowledge Graph

Related Hypotheses (27)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.41
LRP1-Dependent Tau Uptake Disruption
Score: 0.53
Purinergic Signaling Polarization Control
Score: 0.63
Mechanosensitive Ion Channel Reprogramming
Score: 0.59
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.54

Related Analyses (30)

4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Senescent cell clearance as neurodegeneration therapy
neurodegeneration · completed
What is the actual quantitative contribution of FcRn-mediate
neuropharmacology · completed
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · completed
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived

Related Experiments (14)

4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40
Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.40
CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.40
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40

See Also (15)

vitamin-d-therapy-neurodegeneration
therapeutic · Pages share 5 hypotheses
siRNA and RNA Therapeutics Brain Delivery
therapeutic · Pages share 5 hypotheses
sglt2-inhibitors-neurodegeneration
therapeutic · Pages share 5 hypotheses
RIPK1 Inhibitors for Neurodegeneration
therapeutic · Pages share 5 hypotheses
Nanoparticle Drug Delivery for Neurodegeneration
therapeutic · Pages share 5 hypotheses